Atrial Fibrillation Ablation in Adults With Repaired Congenital Heart Disease

Area of Science:

• Cardiology and Electrophysiology
• Congenital Heart Disease (CHD) Research
• Cardiac Ablation Techniques

Background:

• Rising incidence of atrial fibrillation (AF) in adults with congenital heart disease (CHD) due to increased life expectancy and prolonged exposure to cardiac stress.
• Limitations of pharmacological treatments for AF in CHD patients, often proving ineffective and associated with adverse events.
• Growing need for advanced therapeutic options for AF management in this complex patient population.

Approach:

• Utilizing intracardiac echocardiography (ICE) for safe and effective transseptal puncture and left atrial (LA) procedures.
• Employing antral isolation of pulmonary veins as a primary ablation strategy, particularly in cases with atrial septal defects.
• Evaluating the efficacy and safety of AF ablation in a cohort of repaired CHD adults.

Key Points:

• Intracardiac echocardiography (ICE) is crucial for successful and safe transseptal access and ablation in the left atrium (LA) of repaired CHD adults.
• Pulmonary vein antrum isolation demonstrated comparable one-year success rates to those observed in the general population for AF ablation in CHD.
• AF ablation provides a viable and effective therapeutic alternative for CHD patients unresponsive to or experiencing adverse effects from pharmacological management.

Conclusions:

• AF ablation represents a significant advancement in managing atrial fibrillation in adults with congenital heart disease.
• The findings support AF ablation as a safe and effective strategy, expanding treatment options beyond conventional pharmacological approaches.
• Further research into ablation outcomes in diverse CHD subtypes is warranted to optimize patient care.